Top Management Presentation
Financial Results for Fiscal 2011
(April 1, 2011 to March 31, 2012)

from the beginning

Top Management Presentation Financial Results for Fiscal 2011 (April 1, 2011 to March 31, 2012)

presenter :

Joji Nakayama
President and CEO

• Financial Overview

• Overview of FY2011 Results and FY2012 Forecast

• Overview of FY2011 Results - compared with FY2010 results -(1)

• Overview of FY2011 Results - compared with FY2010 results -(2)

• Overview of FY2011 Results - compared with FY2010 results -(3)

• Overview of FY2012 Forecast - compared with FY2011 results -(1)

• Overview of FY2012 Forecast - compared with FY2011 results -(2)

• Sales of Olmesartan (Local Currency Basis)

• Effient/Efient Global Sales

• Sales of Major Products

• Forecast for Second Mid-Term Business Management Plan and Future Management Issues

• Forecast for Second Mid-Term Business Management Plan

• Results and Business Environment Changes During Period of Second Mid-Term Business Management Plan

• Mid- to Long-Term Management Issues: Evolution of Hybrid Business Model

Global Research & Development

presenter :

Glenn Gormley MD PhD
Global Head of R&D
Senior Executive Officer

• My Expectations of Global R&D

• My Priorities of Global R&D

• My Priorities of Japan R&D

• Global R&D Strategy Map

• Global R&D - FY2012 Objectives -

• Major R&D Pipeline

• R&D Projects Key Milestones in FY2012

Mission

presenter :

Arun Sawhney
CEO & MD, Ranbaxy

＠Safe Harbor

Overview & Current Status

• Overview(1)

• Overview(2)

• Timelines

• Global Presence

• Research & Development - Overview

• Key Achievements/ Financial Position for 2011

• Atorvastatin (LipitorR) Market Share

• Forex

Mid-term Growth Strategy

• Ranbaxy Organizational Priorities

• Business(1)

• Business(2)

• R&D and Manufacturing

Collaboration with Daiichi Sankyo

• Daiichi Sankyo Partnership: Strategic Synergies

• Daiichi Sankyo Partnership: Functional Synergies

• Daiichi Sankyo Partnership(1)

• Daiichi Sankyo Partnership(2)

@Thank You

PartI Q&A

• Q&A1

• Q&A2

• Q&A3

• Q&A4

• Q&A5

• Q&A6

• Q&A7

PartII Q&A

• Q&A1

• Q&A2

• Q&A3

• Q&A4

• Q&A5

• Q&A6